Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The primary objective is to compare the pharmacokinetics (PK) profiles among five NP101
patches in healthy volunteers.
The secondary objective is to evaluate the safety of NP101 in healthy volunteers.